1. Home
  2. BVFL vs STRO Comparison

BVFL vs STRO Comparison

Compare BVFL & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BVFL

BV Financial Inc.

HOLD

Current Price

$22.25

Market Cap

176.4M

Sector

Finance

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$9.10

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVFL
STRO
Founded
1873
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.4M
181.4M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
BVFL
STRO
Price
$22.25
$9.10
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $47.23
AVG Volume (30 Days)
14.8K
★ 297.0K
Earning Date
10-23-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.19
N/A
EPS
★ 0.55
N/A
Revenue
N/A
★ $38,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$39.75
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$16.13
$0.72
52 Week High
$22.70
$43.85

Technical Indicators

Market Signals
Indicator
BVFL
STRO
Relative Strength Index (RSI) 54.05 21.65
Support Level $20.36 N/A
Resistance Level $21.86 $16.99
Average True Range (ATR) 0.44 1.24
MACD 0.05 -0.18
Stochastic Oscillator 49.09 9.64

Price Performance

Historical Comparison
BVFL
STRO

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. It operates in one segment commercial banking. The company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: